254 related articles for article (PubMed ID: 22535619)
1. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
Li Y; Nuij VJ; Baars JE; Biermann K; Kuipers EJ; Peppelenbosch MP; de Haar C; Janneke van der Woude C
Inflamm Bowel Dis; 2013 Jan; 19(1):132-40. PubMed ID: 22535619
[TBL] [Abstract][Full Text] [Related]
2. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
[TBL] [Abstract][Full Text] [Related]
3. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
[TBL] [Abstract][Full Text] [Related]
4. STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.
Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Mol Med; 2012 Dec; 18(1):1412-9. PubMed ID: 23154639
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis.
Miyanaka Y; Ueno Y; Tanaka S; Yoshioka K; Hatakeyama T; Shimamoto M; Sumii M; Chayama K
World J Gastroenterol; 2007 Jun; 13(21):2939-44. PubMed ID: 17589943
[TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis.
Hassan EA; Ramadan HK; Ismael AA; Mohamed KF; El-Attar MM; Alhelali I
Saudi J Gastroenterol; 2017; 23(4):238-245. PubMed ID: 28721978
[TBL] [Abstract][Full Text] [Related]
8. Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis.
Olsen T; Rismo R; Gundersen MD; Paulssen EJ; Johnsen K; Kvamme JM; Goll R; Florholmen J
Cytokine; 2016 Mar; 79():90-5. PubMed ID: 26775117
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
[TBL] [Abstract][Full Text] [Related]
10. Histological healing after infliximab induction therapy in children with ulcerative colitis.
Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
[TBL] [Abstract][Full Text] [Related]
11. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
Bryant RV; Burger DC; Delo J; Walsh AJ; Thomas S; von Herbay A; Buchel OC; White L; Brain O; Keshav S; Warren BF; Travis SP
Gut; 2016 Mar; 65(3):408-14. PubMed ID: 25986946
[TBL] [Abstract][Full Text] [Related]
12. Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.
Calafat M; Lobatón T; Hernández-Gallego A; Mañosa M; Torres P; Cañete F; Cabré E; Ojanguren I; Domènech E
Dig Liver Dis; 2017 Dec; 49(12):1327-1331. PubMed ID: 28958412
[TBL] [Abstract][Full Text] [Related]
13. Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis.
Kevans D; Kirsch R; Dargavel C; Kabakchiev B; Riddell R; Silverberg MS
Inflamm Bowel Dis; 2020 Oct; 26(11):1722-1729. PubMed ID: 31883337
[TBL] [Abstract][Full Text] [Related]
14. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
[TBL] [Abstract][Full Text] [Related]
17. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
Patel A; Panchal H; Dubinsky MC
Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission.
Wakai M; Hayashi R; Tanaka S; Naito T; Kumada J; Nomura M; Takigawa H; Oka S; Ueno Y; Ito M; Chayama K
BMC Gastroenterol; 2020 Apr; 20(1):85. PubMed ID: 32245401
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission.
Feagins LA; Melton SD; Iqbal R; Dunbar KB; Spechler SJ
Inflamm Bowel Dis; 2013 Jun; 19(7):1477-82. PubMed ID: 23702713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
